InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Weissman James B, Chief Operating Officer. Director active across 1 companies, notably Dicerna Pharmaceuticals Inc. Aggregated, 6 filings have been recorded. The latest transaction was disclosed on 28 December 2021 — U. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€611,05318,100 shares@ €33.759872.6% of flow
Common Stock
SEC:0001399529-21-000205·
€611,05318,100 shares@ €33.759836.3% of flow
Common Stock
SEC:0001399529-21-000205:0·
3,775 shares
Common Stock
SEC:0001399529-21-000175·
3,775 shares
Common Stock
SEC:0001399529-21-000175:0·
€230,62230,000 shares@ €7.687427.4% of flow
Common Stock
SEC:0001399529-21-000132·
€230,62230,000 shares@ €7.687413.7% of flow
Common Stock
SEC:0001399529-21-000132:0·
6 of 6 declarations
About Weissman James B
James B. Weissman is the Chief Operating Officer and Executive Vice President at Dicerna Pharmaceuticals Inc. He oversees the company's operations and is responsible for implementing operational strategies. With significant experience in the biopharmaceutical sector, he plays a key role in Dicerna's growth and innovation. His leadership is essential in achieving the company's objectives.
